Maria Luisa Barcena

Dr. Maria Luisa Barcena

Charité - Universitätsmedizin Berlin, Berlin, Germany
orcid
Eberhard Karls University of Tuebingen

Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2012 in Brain, Behavior, and Immunity
Verified
Journal Article
Closed access
JAJulia Arnold
Julia Arnold
Maria Luisa BarcenaMaria Luisa Barcena
Maria Luisa Barcena
CRCarola Rüster
Carola Rüster
GVGiuseppe F. Vercellino
Giuseppe F. Vercellino
VCVito Chiantera
Vito Chiantera
SMSylvia Mechsner
Sylvia Mechsner

8 April 2019 in Aging
Verified
Journal Article
Open access
Maria Luisa BarcenaMaria Luisa Barcena
Maria Luisa Barcena
SPSofya Pozdniakova
Sofya Pozdniakova
AKAnja A. Kühl
Anja A. Kühl
IBIstván Baczkó
István Baczkó
YLYury Ladilov
Yury Ladilov
VRVera Regitz-Zagrosek
Vera Regitz-Zagrosek
Aging is associated with increased inflammation and alterations in mitochondrial biogenesis, which promote the development of cardiovascular diseases. Emerging evidence suggests a role for sirtuins, which are NAD+-dependent deacetylases, in the regulation of cardiovascular inflammation and mitochondrial biogenesis. Sirtuins are regulated by sex or sex hormones and are decreased during aging in animal models. We hypothesized that age-related alterations in cardiac Sirt1 and Sirt3 occur in the human heart and examined whether these changes are associated with a decrease in anti-oxidative defense, inflammatory state and mitochondrial biogenesis. Using human ventricular tissue from young (17-40 years old) and old (50-68 years old) individuals, we found significantly lower Sirt1 and Sirt3 expression in old female hearts than in young female hearts. Additionally, lower expression of the anti-oxidative protein SOD2 was observed in old female hearts than in young female hearts. Aging in female hearts was associated with a significant increase in the number of cardiac macrophages and pro-inflammatory cytokines, as well as NF-kB upregulation, indicating a pro-inflammatory shift. Aging-associated pathways in the male hearts were different, and no changes in Sirt1 and Sirt3 or cardiovascular inflammation were observed. In conclusion, the present study revealed a female sex-specific downregulation of Sirt1 and Sirt3 in aged hearts, as well as a decline in mitochondrial anti-oxidative defense and a pro-inflammatory shift in old female hearts but not in male hearts.

16 March 2022 in Cells
Verified
Journal Article
Open access
PDF file
Maria Luisa BarcenaMaria Luisa Barcena
Maria Luisa Barcena
MAMuhammad Aslam
Muhammad Aslam
SPSofya Pozdniakova
Sofya Pozdniakova
KNKristina Norman
Kristina Norman
Yury LadilovYury Ladilov
Yury Ladilov
Aging is one of the major non-reversible risk factors for several chronic diseases, including cancer, type 2 diabetes, dementia, and cardiovascular diseases (CVD), and it is a key cause of multimorbidity, disability, and frailty (decreased physical activity, fatigue, and weight loss). The underlying cellular mechanisms are complex and consist of multifactorial processes, such as telomere shortening, chronic low-grade inflammation, oxidative stress, mitochondrial dysfunction, accumulation of senescent cells, and reduced autophagy. In this review, we focused on the molecular mechanisms and translational aspects of cardiovascular aging-related inflammation, i.e., inflammaging.

1 March 2011 in Fertility and Sterility
Verified
Journal Article
Closed access
Maria Luisa BarcenaMaria Luisa Barcena
Maria Luisa Barcena
JAJulia Arnold
Julia Arnold
FVFiliberto Vercellino
Filiberto Vercellino
VCVito Chiantera
Vito Chiantera
ASAchim Schneider
Achim Schneider
Sylvia MechsnerSylvia Mechsner
Sylvia Mechsner

1 May 2013 in Cytokine
Verified
Journal Article
Closed access
Maria Luisa BarcenaMaria Luisa Barcena
Maria Luisa Barcena
JAJulia Arnold
Julia Arnold
HLHelene Lang
Helene Lang
GVGiuseppe Filiberto Vercellino
Giuseppe Filiberto Vercellino
VCVito Chiantera
Vito Chiantera
SMSylvia Mechsner
Sylvia Mechsner

28 May 2021 in Frontiers in Immunology
Verified
Journal Article
Open access
Maria Luisa BarcenaMaria Luisa Barcena
Maria Luisa Barcena
SJSarah Jeuthe
Sarah Jeuthe
MNMaximilian H. Niehues
Maximilian H. Niehues
SPSofya Pozdniakova
Sofya Pozdniakova
NHNatalie Haritonow
Natalie Haritonow
VRVera Regitz-Zagrosek
Vera Regitz-Zagrosek
Increasing evidence suggests male sex as a potential risk factor for a higher incidence of cardiac fibrosis, stronger cardiac inflammation, and dilated cardiomyopathy (DCM) in human myocarditis. Chronic activation of the immune response in myocarditis may trigger autoimmunity. The experimental autoimmune myocarditis (EAM) model has been well established for the study of autoimmune myocarditis, however the role of sex in this pathology has not been fully explored. In this study, we investigated sex differences in the inflammatory response in the EAM model. We analyzed the cardiac function, as well as the inflammatory stage and fibrosis formation in the heart of EAM male and female rats. 21 days after induction of EAM, male EAM rats showed a decreased ejection fraction, stroke volume and cardiac output, while females did not. A significantly elevated number of infiltrates was detected in myocardium in both sexes, indicating the activation of macrophages following EAM induction. The level of anti-inflammatory macrophages (CD68+ ArgI+) was only significantly increased in female hearts. The expression of Col3A1 and fibrosis formation were more prominent in males. Furthermore, prominent pro-inflammatory factors were increased only in male rats. These findings indicate sex-specific alterations in the inflammatory stage of EAM, with a pro-inflammatory phenotype appearing in males and an anti-inflammatory phenotype in females, which both significantly affect cardiac function in autoimmune myocarditis.